United Kingdom · Biopharma startup
United Kingdom · Aiolos Bio
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Funding reportedLast round: Series A
Follow Aiolos Bio and see its new rounds in your feed.Start following
What company datasets say Aiolos Bio raised
Funding, as reported
Reported in all245Min the source's currency
Rounds1
Last roundSeries A
Last round dateOct 2023
Investors listed5
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Aiolos Bio in front of investors. Or tell us what we have wrong.